Playback speed
10 seconds
ESMO GI 2024 Insights: DEEPER Trial - m-FOLFOXIRI + Cetuximab vs. Bevacizumab in Right-Sided/BRAF Mutant mCRC
By
Insights from 2024 ESMO GI Annual Meeting
FEATURING
Yu Sunakawa
By
Insights from 2024 ESMO GI Annual Meeting
FEATURING
Yu Sunakawa
0 views
July 11, 2024
Comments 0
Login to view comments.
Click here to Login